Clinical Trial EndPoint

Elderly patient old old age alzheimers parkinsons assisted living hospice

Biotech

Athersys stock plunges 60% after stroke stem cell therapy miss

Athersys’ shares nosedived over 60% after its stem cell therapy for stroke failed to meet the primary endpoint of a phase 2/3 trial.

James Waldron May 20, 2022 10:26am

Doctor and patient with hand-held device

Icon to validate PROs as measurement of FDA clinical endpoints

Feb 22, 2017 10:45am